AL

Altay Therapeutics

YC W20

San Francisco, US · Founded 2019 · 6 employees · 1 known investors

altaytherapeutics.com ↗

Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer. The company's pipeline includes oral drug candidates designed as first- or best-in-class therapeutics for oncology and inflammatory conditions.

Founders & leadership· Y Combinator alumni (W20)

Ali OzesinFounder

Osman OzesinFounder

Investors · 1

Y

Y CombinatorSan Francisco · $500K – $500K